Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
CAS RN: 59865-13-3 | Product Number: C2408
Cyclosporin A
Purity: >97.0%(HPLC)(N)
- Cyclosporin
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | C2408 |
Purity / Analysis Method
|
>97.0%(HPLC)(N) |
| Molecular Formula / Molecular Weight | C__6__2H__1__1__1N__1__1O__1__2 = 1,202.64 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
Packaging and Container
|
100MG-Glass Bottle with Plastic Insert (View image), 1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 59865-13-3 |
| Reaxys Registry Number | 3647785 |
| PubChem Substance ID | 125307331 |
| Merck Index (14) | 2752 |
| MDL Number | MFCD00274558 |
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 97.0 area% |
| Purity(with Total Nitrogen) | min. 97.0 % |
| Melting point | 145.0 to 150.0 °C |
| Specific rotation [a]20/D | -185 to -193 deg(C=0.5, MeOH) |
| NMR | confirm to structure |
| Melting Point | 151 °C |
| Specific Rotation | -193° (C=0.5,MeOH) |
| Solubility (soluble in) | Chloroform |
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H302 : Harmful if swallowed. H360 : May damage fertility or the unborn child. H362 : May cause harm to breast-fed children. H350 : May cause cancer. |
| Precautionary Statements | P263 : Avoid contact during pregnancy and while nursing. P260 : Do not breathe dust. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. |
| RTECS# | GZ4120000 |
| HS Number | 2933790090 |
Reference
- Endoplasmic reticulum vacuolation and unfolded protein response leading to paraptosis like cell death in cyclosporine A treated cancer cervix cells is mediated by cyclophilin B inhibition
- 1) Assessing the impact of cyclosporin A on lentiviral transduction and preservation of human hematopoietic stem cells in clinically relevant ex vivo gene therapy settings
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
- Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
- The mechanism of action of cyclosporin A and FK506
- Cyclosporin A, FK-506, and rapamycin: Pharmacologic probes of lymphocyte signal transduction
- Mechanisms of action of cyclosporine
- Complex contribution of cyclophilin D to Ca2+-induced permeability transition in brain mitochondria, with relation to the bioenergetic state
- Inhibition of cyclophilin D by cyclosporin A promotes retinal ganglion cell survival by preventing mitochondrial alteration in ischemic injury
References
References
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.